Williams Emily C, Hahn Judith A, Saitz Richard, Bryant Kendall, Lira Marlene C, Samet Jeffrey H
Veterans Health Administration (VA) Health Services Research and Development, Center of Innovation for Veteran-Centered and Value-Driven Care, Seattle, Washington.
Department of Health Services, University of Washington, Seattle, Washington.
Alcohol Clin Exp Res. 2016 Oct;40(10):2056-2072. doi: 10.1111/acer.13204. Epub 2016 Sep 22.
Alcohol use is common among people living with human immunodeficiency virus (HIV). In this narrative review, we describe literature regarding alcohol's impact on transmission, care, coinfections, and comorbidities that are common among people living with HIV (PLWH), as well as literature regarding interventions to address alcohol use and its influences among PLWH. This narrative review identifies alcohol use as a risk factor for HIV transmission, as well as a factor impacting the clinical manifestations and management of HIV. Alcohol use appears to have additive and potentially synergistic effects on common HIV-related comorbidities. We find that interventions to modify drinking and improve HIV-related risks and outcomes have had limited success to date, and we recommend research in several areas. Consistent with Office of AIDS Research/National Institutes of Health priorities, we suggest research to better understand how and at what levels alcohol influences comorbid conditions among PLWH, to elucidate the mechanisms by which alcohol use is impacting comorbidities, and to understand whether decreases in alcohol use improve HIV-relevant outcomes. This should include studies regarding whether state-of-the-art medications used to treat common coinfections are safe for PLWH who drink alcohol. We recommend that future research among PLWH include validated self-report measures of alcohol use and/or biological measurements, ideally both. Additionally, subgroup variation in associations should be identified to ensure that the risks of particularly vulnerable populations are understood. This body of research should serve as a foundation for a next generation of intervention studies to address alcohol use from transmission to treatment of HIV. Intervention studies should inform implementation efforts to improve provision of alcohol-related interventions and treatments for PLWH in healthcare settings. By making further progress on understanding how alcohol use affects PLWH in the era of HIV as a chronic condition, this research should inform how we can mitigate transmission, achieve viral suppression, and avoid exacerbating common comorbidities of HIV and alcohol use and make progress toward the 90-90-90 goals for engagement in the HIV treatment cascade.
酒精使用在人类免疫缺陷病毒(HIV)感染者中很常见。在这篇叙述性综述中,我们描述了有关酒精对HIV感染者(PLWH)中常见的传播、护理、合并感染和合并症影响的文献,以及有关解决PLWH酒精使用及其影响的干预措施的文献。这篇叙述性综述将酒精使用确定为HIV传播的一个风险因素,以及影响HIV临床表现和管理的一个因素。酒精使用似乎对常见的HIV相关合并症具有相加和潜在的协同作用。我们发现,迄今为止,改变饮酒行为并改善HIV相关风险和结局的干预措施取得的成功有限,我们建议在几个领域开展研究。与艾滋病研究办公室/国立卫生研究院的优先事项一致,我们建议开展研究,以更好地了解酒精如何以及在何种程度上影响PLWH的合并症,阐明酒精使用影响合并症的机制,并了解减少酒精使用是否能改善与HIV相关的结局。这应包括关于用于治疗常见合并感染的最新药物对饮酒的PLWH是否安全的研究。我们建议,未来对PLWH的研究应包括经过验证的酒精使用自我报告测量方法和/或生物学测量方法,理想情况下两者都有。此外,应确定关联中的亚组差异,以确保了解特别脆弱人群的风险。这一系列研究应作为下一代干预研究的基础,以解决从HIV传播到治疗过程中的酒精使用问题。干预研究应为改善医疗环境中PLWH酒精相关干预措施和治疗的提供情况的实施工作提供信息。通过在理解酒精使用如何在HIV作为慢性病的时代影响PLWH方面取得进一步进展,这项研究应告知我们如何减轻传播、实现病毒抑制、避免加剧HIV和酒精使用的常见合并症,并朝着HIV治疗级联参与的90-90-90目标取得进展。